Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Zoom
ZM
|
+$96M |
| 2 |
Match Group
MTCH
|
+$81.3M |
| 3 |
Peloton Interactive
PTON
|
+$75.6M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$55.6M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$50.7M |
Top Sells
| 1 |
Apple
AAPL
|
+$201M |
| 2 |
Microsoft
MSFT
|
+$112M |
| 3 |
IAC Inc
IAC
|
+$77.1M |
| 4 |
Amazon
AMZN
|
+$73.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$52.8M |
Sector Composition
| 1 | Technology | 26.26% |
| 2 | Healthcare | 14.68% |
| 3 | Consumer Discretionary | 13.69% |
| 4 | Communication Services | 10.36% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Matador Resources
MTDR
$6.05B
| $2.07M | ﹤0.01% |
251,002
+3,700
| +1% | +$30.6K |
|
|
ATRI
1702
DELISTED
Atrion Corp
ATRI
| $2.07M | ﹤0.01% |
3,302
| – | – |
|
1703
NETGEAR
NTGR
$837M
| $2.07M | ﹤0.01% |
67,000
+1,300
| +2% | +$40.1K |
|
|
KRTX
1704
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $2.06M | ﹤0.01% |
26,700
+500
| +2% | +$38.7K |
|
1705
Cactus
WHD
$2.84B
| $2.06M | ﹤0.01% |
107,400
+2,300
| +2% | +$44.1K |
|
1706
Empire State Realty Trust
ESRT
$1.35B
| $2.06M | ﹤0.01% |
336,100
-5,300
| -2% | -$32.4K |
|
|
MODN
1707
DELISTED
MODEL N, INC.
MODN
| $2.06M | ﹤0.01% |
58,300
+2,400
| +4% | +$84.7K |
|
1708
Calix
CALX
$4.13B
| $2.05M | ﹤0.01% |
115,500
+1,700
| +1% | +$30.2K |
|
1709
Intellia Therapeutics
NTLA
$1.24B
| $2.05M | ﹤0.01% |
103,100
+1,500
| +1% | +$29.8K |
|
1710
Acadia Realty Trust
AKR
$2.59B
| $2.05M | ﹤0.01% |
195,100
+11,700
| +6% | +$123K |
|
1711
Greif
GEF
$3.58B
| $2.05M | ﹤0.01% |
56,500
+900
| +2% | +$32.6K |
|
|
SAFE
1712
Safehold
SAFE
$1.19B
| $2.04M | ﹤0.01% |
35,541
| – | – |
|
1713
Huron Consulting
HURN
$2.42B
| $2.04M | ﹤0.01% |
51,800
+1,500
| +3% | +$59K |
|
|
GNMK
1714
DELISTED
GenMark Diagnostics, Inc
GNMK
| $2.04M | ﹤0.01% |
143,300
+4,400
| +3% | +$62.5K |
|
1715
Standard Motor Products
SMP
$892M
| $2.03M | ﹤0.01% |
45,500
+400
| +0.9% | +$17.9K |
|
1716
AZZ Inc
AZZ
$3.55B
| $2.02M | ﹤0.01% |
59,300
+700
| +1% | +$23.9K |
|
|
TRHC
1717
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $2.02M | ﹤0.01% |
49,600
+2,500
| +5% | +$102K |
|
|
WW
1718
DELISTED
WW International
WW
| $2.02M | ﹤0.01% |
107,100
+1,800
| +2% | +$34K |
|
1719
Atara Biotherapeutics
ATRA
$85.1M
| $2M | ﹤0.01% |
6,164
+92
| +2% | +$29.8K |
|
|
HSKA
1720
DELISTED
Heska Corp
HSKA
| $2M | ﹤0.01% |
20,200
+3,600
| +22% | +$356K |
|
1721
Warrior Met Coal
HCC
$3.12B
| $1.98M | ﹤0.01% |
116,000
+1,900
| +2% | +$32.4K |
|
1722
XPeng
XPEV
$19.6B
| $1.98M | ﹤0.01% |
+98,600
| New | +$1.98M |
|
1723
Regenxbio
RGNX
$468M
| $1.97M | ﹤0.01% |
71,700
+1,200
| +2% | +$33K |
|
|
INVX
1724
Innovex International, Inc.
INVX
$1.15B
| $1.97M | ﹤0.01% |
79,500
-1,300
| -2% | -$32.2K |
|
1725
Carpenter Technology
CRS
$12.3B
| $1.97M | ﹤0.01% |
108,300
+1,600
| +1% | +$29.1K |
|